Patents by Inventor COSMO TECHNOLOGIES LIMITED

COSMO TECHNOLOGIES LIMITED has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING INTESTINAL DISEASES PRESENTING AT LEAST ONE INFLAMMATORY COMPONENT
    Publication number: 20130225537
    Abstract: The present disclosure relates to methods for treating intestinal diseases presenting at least one inflammatory component such as inflammatory bowel disease or diverticular disease and/or maintaining remission of intestinal diseases presenting at least one inflammatory component such as inflammatory bowel disease (IBD) or diverticular disease using budesonide MMX compositions.
    Type: Application
    Filed: April 5, 2013
    Publication date: August 29, 2013
    Applicants: SANTARUS, INC., COSMO TECHNOLOGIES LIMITED
    Inventors: Cosmo Technologies Limited, Santarus, Inc.
  • METHOD FOR TREATING INTESTINAL DISEASES PRESENTING AT LEAST ONE INFLAMMATORY COMPONENT
    Publication number: 20130209559
    Abstract: The present disclosure relates to methods for treating intestinal diseases presenting at least one inflammatory component such as inflammatory bowel disease or diverticular disease and/or maintaining remission of intestinal diseases presenting at least one inflammatory component such as inflammatory bowel disease (IBD) or diverticular disease using budesonide MMX compositions.
    Type: Application
    Filed: February 13, 2013
    Publication date: August 15, 2013
    Applicants: SANTARUS, INC., COSMO TECHNOLOGIES LIMITED
    Inventors: COSMO TECHNOLOGIES LIMITED, Santarus, Inc
  • CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITION
    Publication number: 20130053360
    Abstract: Controlled release and taste masking compositions containing one or more active principles inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrophilic matrices. The use of a plurality of systems for the control of the dissolution of the active ingredient modulates the dissolution rate of the active ingredient in aqueous and/or biological fluids, thereby controlling the release kinetics in the gastrointestinal tract.
    Type: Application
    Filed: October 25, 2012
    Publication date: February 28, 2013
    Applicant: COSMO TECHNOLOGIES LIMITED
    Inventor: COSMO TECHNOLOGIES LIMITED